ESPE Abstracts (2015) 84 P-2-454

ESPE2015 Poster Category 2 Growth (38 abstracts)

Growth Pattern in Children Affected of Lowe Syndrome – Descriptive Multicentre International Study: Preliminary Data

Larisa Suarez-Ortega a , Anna Casteràs Román b , Marisa Loranca c , Jaime Sánchez del Pozo d & Rare Commons Group e


aDivision of Pediatric Endocrinology, Hospital Sant Joan de Déu, Barcelona, Spainp; bDivision of Endocrinology, Hospital Vall d’Hebron, Barcelona, Spain; cPediatric Endocrinology, Madrid, Spain; dDivision of Pediatric Endocrinology, Hospital Universitario 12 de Octubre, Madrid, Spain; ewww.rarecommons.org, Hospital Sant Joan de Déu, Esplugues, Barcelona, Spain


Background: Lowe syndrome or oculocerebrorenal syndrome is a very rare condition (1:50 000) caused by mutations in the OCRL1 gene. It is an x-linked disorder characterized by congenital cataracts, renal tubular dysfunction, neurological defects (generalized hypotonia and mental retardation) and growth disorders. Growth pattern in Lowe syndrome has not been described in population-based studies so far.

Objective: Descriptive multicenter international study aimed to describe growth pattern in Lowe syndrome affected subjects.

Method: 47 subjects have been identified around the world. Auxologic data of 14 subjects (age 3–24 years) with Lowe syndrome from Spain (n=8), Italy (n=5) and Argentina (n=1) were reported through a web-based questionnaire.

Results: Length/height is expressed as followed in media±S.D. 3 month: 61.2±2.75; 6 month: 65.8±1.94; 9 month: 69.7±2.39; 12 month: 71.3 cm±4.97; 18 month: 75.4 cm±3.37; 2 years: 78.9±7.13; 3 years: 84.6±7.43; 4 years: 86.8±6.38; 5 years: 90.4±7.82; 6 years: 96.8±5.19; 7 years: 102±5.29; 8 years: 106.2±4.54; 9 years: 111.3±4.92; 10 years: 118.3±1.53; 12 years: 124.3±0.35. Only one subject older than 13 years was identified with the following height measurements: height at the age of 13, 15, 16 and 23 were 130, 135, 149 and 158 cm respectively.

Conclusion: Data regarding growth patterns of children affected of Lowe-syndrome would enhance to design specific growth charts for children with this condition. Lowe syndrome as well as other rare conditions requires joint efforts and advocacy of both healthcare members and patient’s families to go further in the knowledge of the disease. ‘Rare Commons’ online platform is a collaborative project network (including families and doctors) to gain knowledge in rare diseases.

Volume 84

54th Annual ESPE (ESPE 2015)

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.